Impact of the 10-valent pneumococcal conjugate vaccine on hospital admissions in children under three years of age in Iceland.

[1]  B. Hrafnkelsson,et al.  Reduction in All-Cause Acute Otitis Media in Children <3 Years of Age in Primary Care Following Vaccination With 10-Valent Pneumococcal Haemophilus influenzae Protein-D Conjugate Vaccine: A Whole-Population Study , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Marie Gisselsson-Solen.  Trends in Otitis Media Incidence After Conjugate Pneumococcal Vaccination: A National Observational Study , 2017, The Pediatric infectious disease journal.

[3]  Eyal Oren,et al.  Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory tract infections in 195 countries: a systematic analysis for the Global Burden of Disease Study 2015 , 2017, The Lancet. Infectious diseases.

[4]  C. Toscano,et al.  Direct and indirect impact of 10-valent pneumococcal conjugate vaccine introduction on pneumonia hospitalizations and economic burden in all age-groups in Brazil: A time-series analysis , 2017, PloS one.

[5]  B. Henriques-Normark,et al.  Effect of high-valency pneumococcal conjugate vaccines on invasive pneumococcal disease in children in SpIDnet countries: an observational multicentre study. , 2017, The Lancet. Respiratory medicine.

[6]  M. Eriksson,et al.  Changing diagnosis coding routines may confound the results of longitudinal childhood pneumonia studies , 2017, Acta paediatrica.

[7]  A. L. Sartori,et al.  Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil , 2017, PloS one.

[8]  E. Eviatar,et al.  Comparison of first year of life acute otitis media admissions before and after the 13-valent pneumococcal conjugate vaccine. , 2017, International journal of pediatric otorhinolaryngology.

[9]  J. Meinzen-Derr,et al.  Pediatric Acute Otitis Media in the Era of Pneumococcal Vaccination , 2017, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[10]  T. Kilpi,et al.  Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study , 2017, PloS one.

[11]  D. Hamer,et al.  Etiology of severe pneumonia in Ecuadorian children , 2017, PloS one.

[12]  P. Cane,et al.  Spread and Evolution of Respiratory Syncytial Virus A Genotype ON1, Coastal Kenya, 2010–2015 , 2017, Emerging infectious diseases.

[13]  Jane C. Deng,et al.  Postviral Complications , 2016, Clinics in Chest Medicine.

[14]  E. Coutinho,et al.  Impact and Effectiveness of 10 and 13-Valent Pneumococcal Conjugate Vaccines on Hospitalization and Mortality in Children Aged Less than 5 Years in Latin American Countries: A Systematic Review , 2016, PloS one.

[15]  Colin Simpson,et al.  Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children , 2016, BMC Infectious Diseases.

[16]  Minh Nhat Le,et al.  Association of RSV-A ON1 genotype with Increased Pediatric Acute Lower Respiratory Tract Infection in Vietnam , 2016, Scientific Reports.

[17]  T. Leegaard,et al.  Etiology of Pneumonia in a Pediatric Population with High Pneumococcal Vaccine Coverage: A Prospective Study , 2016, The Pediatric infectious disease journal.

[18]  B. Hrafnkelsson,et al.  Decreased Incidence of Respiratory Infections in Children After Vaccination with Ten-valent Pneumococcal Vaccine , 2015, The Pediatric infectious disease journal.

[19]  H. D. de Melker,et al.  Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands , 2015, Emerging infectious diseases.

[20]  V. Duvvuri,et al.  Genetic diversity and evolutionary insights of respiratory syncytial virus A ON1 genotype: global and local transmission dynamics , 2015, Scientific Reports.

[21]  N. Andrews,et al.  Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study. , 2015, The Lancet. Infectious diseases.

[22]  M. Virtanen,et al.  Impact of Ten-Valent Pneumococcal Conjugate Vaccination on Invasive Pneumococcal Disease in Finnish Children – A Population-Based Study , 2015, PloS one.

[23]  W. Schaffner,et al.  Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. , 2015, The Lancet. Infectious diseases.

[24]  P. Homøe,et al.  Incidence of Otitis Media in a Contemporary Danish National Birth Cohort , 2014, PloS one.

[25]  A. Berglund,et al.  All-Cause Pneumonia Hospitalizations in Children <2 Years Old in Sweden, 1998 to 2012: Impact of Pneumococcal Conjugate Vaccine Introduction , 2014, PloS one.

[26]  K. Mølbak,et al.  Impact of 13-valent pneumococcal conjugate vaccination in invasive pneumococcal disease incidence and mortality. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  C. Scagnolari,et al.  Rapid spread of the novel respiratory syncytial virus A ON1 genotype, central Italy, 2011 to 2013. , 2014, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[28]  R. Adegbola,et al.  Etiology of Severe Childhood Pneumonia in The Gambia, West Africa, Determined by Conventional and Molecular Microbiological Analyses of Lung and Pleural Aspirate Samples , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  K. Edwards,et al.  The Role of Influenza and Parainfluenza Infections in Nasopharyngeal Pneumococcal Acquisition Among Young Children , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  T. Gudnason,et al.  Bacterial meningitis in children in Iceland, 1975–2010: A nationwide epidemiological study , 2013, Scandinavian journal of infectious diseases.

[31]  C. Whitney,et al.  U.S. hospitalizations for pneumonia after a decade of pneumococcal vaccination. , 2013, The New England journal of medicine.

[32]  Robert E Black,et al.  Global burden of childhood pneumonia and diarrhoea , 2013, The Lancet.

[33]  A. Chandran,et al.  The Worldwide Impact of the Seven-valent Pneumococcal Conjugate Vaccine , 2012, The Pediatric infectious disease journal.

[34]  M. Haggard,et al.  Impact of Pneumococcal Conjugate Vaccination on Otitis Media: A Systematic Review , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  Michal Bromberg,et al.  Invasive bacterial infections in relation to influenza outbreaks, 2006-2010. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  T. Cherian,et al.  Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates , 2009, The Lancet.

[37]  L. Sticchi,et al.  Universal childhood immunisation against Streptococcus pneumoniae: the five-year experience of Liguria Region, Italy. , 2009, Vaccine.

[38]  C. Byington,et al.  Seasonal Invasive Pneumococcal Disease in Children: Role of Preceding Respiratory Viral Infection , 2008, Pediatrics.

[39]  J. McCullers,et al.  Respiratory viruses predisposing to bacterial infections: role of neuraminidase , 2004, The Pediatric infectious disease journal.

[40]  M. Leinonen,et al.  Serologically indicated pneumococcal pneumonia in children: a population‐based study in primary care settings , 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.